期刊文献+

初发急性早幼粒细胞白血病不同治疗方案疗效比较 被引量:3

A comparison of the therapeutic effect between two different treatments in newly diagnosed acute promyelocytic leukemia
原文传递
导出
摘要 2003年以来,我院采用全反式维甲酸(ATRA)、三氧化二砷(ATO)和高三尖杉酯碱(HHT)联合治疗初发急性早幼粒细胞白血病(APL)患者,取得较好的近期和远期疗效。为进一步阐明此三药联合治疗APL的疗效,我们将治疗结果与同期金华市中心医院采用ATRA、ATO、去甲氧柔红霉素(IDA)和甲氨蝶呤(MTX)联合治疗72例初发APL患者的结果进行比较分析。现报道如下。
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2015年第10期862-864,共3页 Chinese Journal of Practical Internal Medicine
关键词 白血病 早幼粒细胞 急性 复发 leukemia, promyelocytic, acute relapse
  • 相关文献

参考文献8

  • 1Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendation of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia[J]. J Clin Oncol, 2003, 21(24): 4642-4649.
  • 2Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/As203 combination yields a high quality remission and survival in newly diagnosed acutepromyelocytic leukemia[J]. Proc Natl Acad Sci USA, 2004, 101(15): 5328-5335.
  • 3Hu J, Liu YF, Wu CF, et al. Long-term efficacy and safety of aU-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia[J]. Proc Natl Acad Sci USA, 2009, 106(9): 3342-3347.
  • 4Kogan C. CuringAPL : Differentiation or destruction?[J]. Cancer Cell, 2009, 15(1): 7-8.
  • 5Lo-Coco F, Awisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia[J]. N EnglJ Med, 2013, 369(2): 111-121.
  • 6WangJX, Mi YC, Fu MW, et al. Application ofhomoharringtonine in the treatment of acute promyelocytic leukemia[J]. Blood(ASH Annual Meeting Abstracts), 2007, 110:1841.
  • 7Lo-Coco F, Avvisati G, Vignetti M, et al. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA- 2000 trial of the GIMEMA Group[J]. Blood, 2010, 116(17): 3171- 3179.
  • 8Grimwade D, Jovanovic JV, Hills RK, et al. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy[J]. J Clin Oncoly, 2009, 27(22): 3650-3658.

同被引文献17

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部